AQST - Aquestive Therapeutics Inc (Healthcare: Drug Manufacturers - Specialty & Generic) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-04-03)
Last
 2.87		 Change
 ⇓ -0.17   (-5.59%)		 Volume
  1,251,538
Open
 2.99		 High
 2.99		 Low
 2.82
8EMA (Daily)
 3.02		 40EMA (Daily)
 3.03		 50EMA (Daily)
 3.08		 STO (Daily)
 56.925		 MACD Hist (Daily)
 0.011
8EMA (Weekly)
 3.032		 40EMA (Weekly)
 3.50		 50EMA (Weekly)
 3.47		 STO (Weekly)
 33.922		 MACD Hist (Weekly)
 -0.049
Company Profile
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. The product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS). Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com